Objective: Primary, to evaluate the usefulness of a comprehensive medication review (CMR) process in screening for adverse drug event (ADE) risk and to measure the impact of pharmacist recommendations; secondary, to evaluate whether screening tools assist in detecting ADEs.
Design: Nonrandomized, prospective pre/post pilot study.
Setting: Wisconsin-based community pharmacy affiliated with a two-campus retirement facility serving independently living older adults.